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The purpose of this study is to clarify the absorption characteristics of drugs across 
the serosal cecal surface membrane occupying a large absorption area in the 
peritoneal cavity in rats.   Absorptions of phenolsulphonphthalein (PSP) and 
fluorescein isothiocyanate-dextrans (FDs) as model drugs after application to the rat 
serosal cecal surface were investigated in rats, employing a cylindrical diffusion cell.   
PSP was absorbed from the rat serosal cecal surface, followed by appearance in the 
plasma and bile.   The time course of the remaining PSP amount in the diffusion cell 
obeyed first-order kinetics, and its rate constant Ka was calculated to be 8.01 x 10-3 
min-1.   No significant difference was seen in the absorption ratio of PSP which was 
approximately 90 % in 6 h among three doses (0.3, 0.5 and 1 mg), suggesting a 
linearity of absorption.   Moreover, the absorption ratios of FDs from the rat serosal 
cecal surface at 3 h decreased with an increase in the molecular weight (24.7% for 





The peritoneal cavity is a potential space for peritoneal dialysis as a long-term renal 
replacement therapy and intraperitoneal (i.p.) chemotherapy of cancer restricted to the 
peritoneal cavity e.g. ovarian carcinoma, and so on.   Although the i.p. route of drugs has 
attracted attention, it has not been clarified whether drug absorption from the peritoneal cavity 
occurs through specific organs.   We previously examined the absorption characteristics of 
several compounds from the liver surface (Nishida et al 1994, 1995a,b, 1996, 1997, 2000) and 
serosal stomach surface (Nakamura et al 1999; Mukai et al 1999) in rats as a series of 
investigations.   Among the peritoneal organs in rats, the cecum is well developed and 
should play an important role in peritoneal drug transport because of its large surface area.   
Although the surface area of the serosal cecum in the human peritoneal cavity is 
proportionally much smaller, the absorption mechanism from the serosal cecal surface needs 
to be examined to estimate the overall in-vivo absorption rate of a drug after i.p. 
administration in human beings from the extrapolation of animal data such as rats. 
 In the present study, we investigated the absorption of an organic anion 
phenolsulphonphthalein as a model after application to the rat serosal cecal surface.   
Furthermore, we selected three fluorescein isothiocyanate-dextrans with different molecular 




Materials and Methods 
Chemicals 
Phenolsulphonphthalein (PSP) was purchased from Nacalai Tesque, Inc. (Kyoto, Japan).   
Fluorescein isothiocyanate-dextrans (FDs) with average molecular weights of 4,400 (FD-4), 
11,000 (FD-10), and 40,500 (FD-40) were obtained from Sigma Chemical Co. (St Louis, MO, 
USA).   All other chemicals were of reagent grade. 
In-vivo experiment 
All animal experiments in the present study conformed to the Guideline for Animal 
Experimentation in Nagasaki University. 
 Male Wistar rats (250 - 316 g) were housed in cages in an air-conditioned room and 
maintained on standard rat foods and water freely available.   The left femoral artery and 
common bile duct of the rats previously anaesthetized with sodium pentobarbitone (50 mg 
kg-1, i.p.) were cannulated with polyethylene tubes.   A cylindrical diffusion cell (i.d. 6 mm, 
area 0.28 cm2) was designed to fit over the rat serosal cecal membrane.   The diffusion cell 
was attached to the rat serosal cecal surface with adhesive chemical Aron Alpha (Sankyo, 
Tokyo, Japan).   The in vivo experiments was performed under closed cavity conditions 
except for the region where the diffusion cell was attached.   A schematic drawing outlining 
the set up of the in vivo experiment was shown in Fig. 1. 
 Each compound was dissolved in 0.05 mL of isotonic phosphate buffer (pH 7.4) and 
added to the diffusion cell directly.   After application to the rat serosal cecal surface, 
plasma, bile, urine and the remaining solution in the diffusion cell were sampled at the 
specified times. 
Analytical methods 
The concentrations of model compounds in the plasma, bile, urine and remaining solution in 
the diffusion cell were determined as follows.   The concentration of free PSP was 
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determined spectrophotometrically at 560 nm after dilution with 1 M NaOH.   The total 
concentration of free PSP and its metabolite was measured in the same manner after they were 
subjected to acid hydrolysis (2 M HCl at 100°C for 30 min) (Hart & Schanker 1966).   The 
concentration of PSP metabolite (glucuronic acid conjugate) was estimated from the 
difference between these values.   The PSP metabolite could not be detected in the plasma. 
 The concentrations of FDs as fluorescence in the solution remaining in the diffusion cell 
were measured by a spectrophotofluorometer at excitation and emission wavelengths of 489 
and 515 nm, respectively. 
Calculation of moment parameters 
The plasma concentration profiles and biliary excretion rate-time curves of free PSP and its 
metabolite were analyzed based on statistical moment theory.   Moment parameters for 
plasma concentration profile of free PSP (AUCp, MRTp) and those for biliary excretion 
rate-time curves of free PSP (AUCb,f, MRTb,f) and its metabolite (AUCb,m, MRTb,m) were 
calculated using a linear trapezoidal formula and extrapolation to infinite time based on a 
monoexponential equation (Yamaoka et al 1978). 
 The overall absorption and excretion process can be evaluated with moment parameters.   
In particular, AUCp and MRTp are useful parameters for roughly evaluating the drug 
absorbability from the peritoneal cavity with regard to extent and rate, respectively.   Also, 
AUCb and MRTb are useful parameters for roughly evaluating the biliary excretion of drug 
with regard to extent and rate, respectively. 
Statistical analysis 
Statistical analysis was performed by applying unpaired Student’s t-test.   P < 0.05 was 
considered to be statistically significant.   All values were expressed as the mean value ± 
standard error of at least four experiments. 
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Results and Discussion 
We established the experimental system utilizing a cylindrical diffusion cell attached to the rat 
serosal cecal surface.   This experimental system enables us to examine drug absorption 
from the serosal cecal surface without interference by absorption from other sites.   We 
selected PSP as a low molecular weight model because their disposition characteristics have 
been investigated previously (Enna & Schanker 1973; Nishida et al 1989; Kakutani et al 
1992). 
Plasma concentration and biliary excretion of PSP after application to the 
serosal cecal surface 
Figure 2A shows the plasma concentration profile of PSP after application to the rat serosal 
cecal surface at doses of 0.3, 0.5 and 1 mg.   PSP appeared in the plasma, suggesting the 
occurrence of drug absorption from the rat serosal cecal surface.   The plasma concentration 
of PSP after application to the rat serosal cecal surface reached a maximum about 1 h after 
dosing (Fig. 2A).   After absorption from the rat serosal cecal surface, PSP was excreted into 
the bile as shown in Fig. 2B.   The metabolite of PSP (glucuronic acid conjugate) was also 
excreted into the bile (Fig. 2C).   Therefore, PSP demonstrated fast absorption from the 
serosal cecal surface, although it is poorly absorbed from the gastrointestinal mucosa because 
it is highly ionized and has a very small partition coefficient at physiological pH (Shanker et 
al 1958). 
 PSP absorbed from the serosal cecal surface tended to be excreted into the urine, 
compared with i.v. administration (Table 1).   The difference in the MRTp values between 
the serosal cecal surface application and i.v. administration corresponded to the mean time 
value for the absorption from the serosal cecal surface (MAT).   MAT of PSP after 
application to the rat serosal cecal surface was calculated to be 75.8 min from the MRTp 
values listed in Table 2. 
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Dose-dependency on PSP absorption from serosal cecal surface 
As shown in Figs 2A, 2B and 2C, the shapes of plasma concentration profiles of free PSP and 
the biliary excretion rate-time curves of free PSP and its metabolite were almost identical 
among 0.3, 0.5 and 1 mg. 
 Recoveries (% of dose) of free PSP and its metabolite in the bile, urine and diffusion cell 
at doses of 0.3, 0.5 and 1 mg are given in Table 1.   Absorption ratios of PSP in 6 h 
calculated from the remaining amount of PSP in the diffusion cell were 85.7, 90.1 and 89.6% 
at doses of 0.3, 0.5 and 1 mg, respectively, indicating that the PSP absorption from the rat 
serosal cecal surface shows no saturation within the dose range used.   The decrease in the 
urinary recovery ratio of PSP metabolite could be responsible for the saturation of the 
metabolic process of PSP at a high dose.   Moreover, the PSP renal clearance after 
application to the rat serosal cecal surface at a dose of 1 mg (0.384 mL min-1) was 
significantly declined (P < 0.05), compared to 0.3 mg (0.808 mL min-1).   This suggests that 
the urinary secretion of PSP is also saturable. 
 Moment parameters for the plasma concentration profiles of free PSP and biliary 
excretion rate-time curves of free PSP and its metabolite are listed in Table 2.   No 
significant difference was seen in the AUCp/dose value among the three doses, suggesting the 
linearity of PSP absorption from the rat serosal cecal surface.   Accordingly, a specific 
transport mechanism such as active transport might not be involved in PSP absorption from 
the rat serosal cecal surface, similar to other organ surfaces (Nishida et al 1995a; Mukai et al 
1999). 
Time course of PSP amount in the diffusion cell after application to the serosal 
cecal surface 
To assess the absorption characteristics from the rat serosal cecal surface, we studied the time 
course of the PSP amount in the diffusion cell (Fig. 3A).   A semi-log plot of the remaining 
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PSP amount in the diffusion cell until 180 min gave a straight line (correlation coefficient: 
0.94) as shown in Fig. 3A, indicating that the PSP absorption from the rat serosal cecal 
surface proceeds via first-order kinetics.   Its first-order absorption rate constant Ka was 
calculated to be 8.01 x 10-3 min-1. 
Absorption of FDs with different molecular weights from the serosal cecal 
surface 
Since there was a significant relation between the molecular weight and absorption rate 
constant after application of model compounds to the liver and serosal stomach surface 
(Nishida et al 1996; Mukai et al 1999), the molecular weight appeared to play an important 
role in drug absorption from the serosal cecal surface.   We selected FDs as model 
macromolecules, and examined the molecular weight dependence of drug absorption from the 
serosal cecal surface in rats because dextrans are fairly resistant to metabolic degradation and 
their in-vivo fate has been characterized fully in rats (Nishida et al 1991; Mehvar & Shepard 
1992; Mehvar et al 1994). 
 Figure 2B shows the time courses of FD-4 and FD-10 recovery in the diffusion cell until 
180 min after application to the rat serosal cecal surface.   This suggests that their 
absorption from the rat serosal cecal surface proceeds via first-order kinetics, similar to a 
small molecule PSP (Fig. 3A).   The Ka values for FD-4 and FD-10 were calculated to be 
1.62 x 10-3 and 0.85 x 10-3 min-1, respectively.   The absorption ratios from the rat serosal 
cecal surface in 3 h were calculated from the amount recovered from the diffusion cell, as 
73.0% for PSP, 24.7% for FD-4, 12.8% for FD-10 and 3.4% for FD-40.   Accordingly, 
comparison of the absorption of several model compounds with different molecular weights 
demonstrated that the absorption ratio decreased with the increase in the molecular weight. 
Comparison of the absorption rates of PSP among the liver, stomach and cecal 
surface 
We compared the absorption rate of PSP from the other previously investigated organ surfaces 
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such as liver (Nishida et al 1995a) and stomach (Nakamura et al 1999) based on the clearance 
concept.   The Ka values of PSP from the other organ surfaces of liver (Nishida et al 1995a) 
and stomach (Nakamura et al 1999) have been obtained by the time courses of PSP recovery 
in the diffusion cell.   We derived the apparent permeability coefficients (Papp) representing 







where Va and Area mean the application volume and effective application area of the diffusion 
cell, respectively. 
 The Papp values of PSP from the liver, stomach and cecal surface were calculated to be 
10.9, 12.3 and 11.2 µm min-1, respectively.   No significant difference was seen in Papp 
among the three organ surfaces, implying that these three organ surface membranes are 
broadly uniform with respect to absorption characteristics. 
 
 In conclusion, the absorption characteristics of the model compounds from the serosal 
cecal surface in rats would be useful to estimate the overall drug absorption rate after i.p. 
administration. 
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Table 1  Recovery (% of dose) of free PSP and its metabolite at 6 h after application to the 
rat serosal cecal surface or i.v. administration 
 
 




(mg) Free Total Free Metabolite Total Free Metabolite 
 
Application to serosal cecal surface 
 
 0.3 14.3 49.6 30.6 19.0 35.3 14.8 20.5 
  ±3.0 ±2.4 ±2.4 ±1.5 ±3.4 ±2.8 ±2.4 
 
 0.5 9.9 54.9 35.2 19.7 30.1 12.3 17.7 
  ±1.9 ±6.2 ±6.4 ±2.4 ±4.7 ±3.7 ±3.0 
 
 1 10.4 54.1 33.6 20.6 29.4 20.7 8.7***,§




 1 - 69.2 42.1 27.1 23.1 16.2 6.9 
   ±4.0 ±2.2 ±3.3 ±5.7 ±4.9 ±1.0 
 
 
Each value is the mean ± s.e. of at least five experiments. 
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 Dose AUCp AUCp/dose MRTp AUCb,f MRTb,f AUCb,m MRTb,m
 
 
(mg) (µg mL-1 min) (min mL-1) (min) (µg) (min) (µg) (min) 
 
Application to serosal cecal surface 
 
 0.3 178.1 0.59 160.5 102.5 163.7 67.7 168.5 
  ±18.2 ±0.06 ±30.8 ±8.6 ±28.9 ±7.5 ±23.7 
 
 0.5 339.3 0.68 180.9 188.9 152.2 111.6 194.5 
  ±47.9 ±0.10 ±21.0 ±34.5 ±7.6 ±10.2 ±21.6 
 
 1 545.0 0.55 151.7 354.7 139.9 220.7 149.2 




 1 1026.3 1.03 75.9 457.3 58.4 301.2 80.1 
 
 









Figure 1   A schematic drawing of in vivo experiment.   A cylindrical diffusion cell was 
attached to the rat serosal cecal surface using Aron Alpha biocompatible glue.   All 
dimensions are approximate. 
 
Figure 2   Plasma concentrations of free PSP (A) and biliary excretion rates of free PSP (B) 
and its metabolite (C) after application to the rat serosal cecal surface at doses of 0.3 (▲), 0.5 
(○) and 1 mg (●).   Each point represents the mean ± s.e. of at least five experiments. 
 
Figure 3  Semi-log plots of the remaining amount of free PSP (●) (A), FD-4 (●) and 
FD-10 (○) (B) in the diffusion cell after application to the rat serosal cecal surface at a dose 
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